Revenue surged 36% to $12.1 million on IRRAflow integration and record equipment placements.

Credit-enhanced loan balances surged 97% as net income hit $10 million.

International surgical sales surged double digits amid domestic restructuring headwinds.

Record pretax income and AI-driven efficiency gains fuel loan origination growth.

Revenue surged 22.7% to $375.9 million as net income jumped 66.4% year over year.

Revenue beat guidance at $134.9 million as digital user growth accelerated.

Surgical revenue grew 9% despite 45% net sales decline from Medicare changes.

Record endpoint IC revenue and M800 momentum drive 17% growth despite capacity constraints.

Refrigerant pricing pressure and channel inventory weighed on revenue and sales volume.

Guidance tightened as customer mix shifts toward foldables and IT displays.

Self-storage recovery accelerates with occupancy gains and margin expansion across markets.

Platform adoption accelerates as AI-driven exposure management gains traction.

VK2735 obesity drug shows up to 22% weight loss with less frequent dosing schedules.

Rising rates pressured home sales and orders in the quarter.

NGS revenue surged 29% as management raised full-year guidance.

Newgard takes helm as gaming FinTech initiatives shift toward launch phase.

Record grain and intermodal volumes drive 15% revenue growth amid fuel headwinds.

Net interest income surged 30% year over year amid strategic review.

Revenue hit $22.9B with adjusted EPS up 28% as optimization gains offset headwinds.

Revenue beat guidance at $1.03B as AI and cybersecurity demand accelerated across both segments.

Record sales and margin expansion driven by iDose TR and Epioxa launches.

Record revenue and net income growth amid rising credit losses.